Novel Technique for Botulinum Toxin Injection to Minimize Patient Discomfort
|ClinicalTrials.gov Identifier: NCT00628472|
Recruitment Status : Completed
First Posted : March 5, 2008
Last Update Posted : March 5, 2008
|Condition or disease||Intervention/treatment|
|Pain||Drug: botulinum type a|
Objective: To investigate whether injection of botulinum toxin type A is less painful if performed through follicular openings versus traditional non-specific approach.
Design: Prospective, randomized, single-blinded study.
Setting: Academic dermatology department.
Patients: A volunteer sample of twenty female patients aged 25-55 who had no prior history of botulinum toxin injection.
Intervention: Each patient received six randomized injections of botulinum toxin type A (Botox® Allergan). Two injections into the procerus muscle and two into each corrugator muscle. Three of the injections were performed through follicular openings and three were performed traditionally.
Main Outcome Measure: Patient discomfort on a 1-10 scale and direct comparison between the two injection techniques.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||21 participants|
|Intervention Model:||Single Group Assignment|
|Primary Purpose:||Supportive Care|
|Official Title:||Novel Technique for Botulinum Toxin Injection to Minimize Patient Discomfort|
|Study Start Date :||January 2007|
|Primary Completion Date :||May 2007|
|Study Completion Date :||May 2007|
Drug: botulinum type a
- Decrease pain on injection for treatment intervention assessed on a 10 point scale [ Time Frame: At time of intervention ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00628472
|United States, Michigan|
|Henry Ford Health System|
|Detroit, Michigan, United States, 48202|
|Principal Investigator:||David M Ozog, MD||Henry Ford Health System|